Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C

키워드

참고문헌 (15)

1. de Franchis R, "Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension", J Hepatol, 43, pp.167~176 (2005)
2. Bruix J, "Management of hepatocellular carcinoma : an update", Hepatology, 53, pp.1020~1022 (2011)
3. European Association For The Study Of The Liver, "EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma", J Hepatol, 56, pp.908~943 (2012)
4. Anthony PP, "The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization", J Clin Pathol, 31, pp.395~414 (1978)
5. Soresi M, "Non invasive tools for the diagnosis of liver cirrhosis", World J Gastroenterol, 20, pp.18131~18150 (2014)
6. Mehta SH, "Exceeding the limits of liver histology markers", J Hepatol, 50, pp.36~41 (2009)
7. Lee CK, "Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a United States cohort : the Boston children’s hospital experience", J Pediatr, 163, pp.1058~1064 (2013)[DOI]
8. Lannerstedt H, "Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver", Scand J Gastroenterol, 48, pp.93~100 (2013)
9. Islam S, "Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers", Scand J Gastroenterol, 40, pp.867~872 (2005)
10. Lok AS, "Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests : results of the HALT-C cohort", Hepatology, 42, pp.282~292 (2005)
11. Gressner AM, "Hyaluronic acid synthesis and secretion by rat liver fat storing cells(perisinusoidal lipocytes)in culture", Biochem Biophys Res Commun, 151, pp.222~229 (1988)
12. Schuppan D, "Serum assays for liver fibrosis", J Hepatol, 22(2 Suppl), pp.82~88 (1995)
13. Gressner OA, "Biomarkers of liver fibrosis : clinical translation of molecular pathogenesis or based on liverdependent malfunction tests", Clin Chim Acta, 381, pp.107~113 (2007)
14. Mölleken C, "Detection of novel biomarkers of liver cirrhosis by proteomic analysis", Hepatology, 49, pp.1257~1266 (2009)
15. Christian Mölleken, "Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillarassociated protein 4 in hepatitis C patients", Clinical and Molecular Hepatology, 25(1), pp.42~51 (2019), 대한간학회

관련 논문AI추천